These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 20645914

  • 1. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals.
    Piwnica-Worms D, Sharma V.
    Curr Top Med Chem; 2010; 10(17):1834-45. PubMed ID: 20645914
    [Abstract] [Full Text] [Related]

  • 2. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.
    Sivapackiam J, Gammon ST, Harpstrite SE, Sharma V.
    Methods Mol Biol; 2010; 596():141-81. PubMed ID: 19949924
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V.
    Dalton Trans; 2010 Jul 07; 39(25):5842-50. PubMed ID: 20505882
    [Abstract] [Full Text] [Related]

  • 4. Single photon emission computed tomography and positron emission tomography imaging of multi-drug resistant P-glycoprotein--monitoring a transport activity important in cancer, blood-brain barrier function and Alzheimer's disease.
    Piwnica-Worms D, Kesarwala AH, Pichler A, Prior JL, Sharma V.
    Neuroimaging Clin N Am; 2006 Nov 07; 16(4):575-89, viii. PubMed ID: 17148020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D.
    J Nucl Med; 2005 Feb 07; 46(2):354-64. PubMed ID: 15695797
    [Abstract] [Full Text] [Related]

  • 7. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo.
    Sharma V, Beatty A, Wey SP, Dahlheimer J, Pica CM, Crankshaw CL, Bass L, Green MA, Welch MJ, Piwnica-Worms D.
    Chem Biol; 2000 May 07; 7(5):335-43. PubMed ID: 10801474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer.
    Kobayashi M, Tsujiuchi T, Okui Y, Mizutani A, Nishi K, Nakanishi T, Nishii R, Fukuchi K, Tamai I, Kawai K.
    Pharm Res; 2018 Nov 29; 36(1):18. PubMed ID: 30498970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I, Gülbaş Z, Ocak S, Kaya E, Alataş F, Vardareli E, Metintaş M.
    J Comput Assist Tomogr; 2007 Nov 29; 31(5):795-9. PubMed ID: 17895794
    [Abstract] [Full Text] [Related]

  • 12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC.
    Phytomedicine; 2016 Mar 15; 23(3):316-23. PubMed ID: 26969385
    [Abstract] [Full Text] [Related]

  • 13. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM, Abrunhosa AJ, Pauwels EK, Botelho MF.
    Cancer Biother Radiopharm; 2009 Apr 15; 24(2):215-27. PubMed ID: 19409044
    [Abstract] [Full Text] [Related]

  • 14. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V.
    Cancer Chemother Pharmacol; 1997 Apr 15; 40 Suppl():S3-8. PubMed ID: 9272126
    [Abstract] [Full Text] [Related]

  • 15. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA, Bagrij T, Neo SY.
    Gen Pharmacol; 1997 May 15; 28(5):639-45. PubMed ID: 9184795
    [Abstract] [Full Text] [Related]

  • 16. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D.
    J Nucl Med; 1998 Jan 15; 39(1):77-86. PubMed ID: 9443741
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska L, Balkay L, Mikecz P, Trón L, Krasznai Z.
    Eur J Nucl Med Mol Imaging; 2003 Aug 15; 30(8):1147-54. PubMed ID: 12830325
    [Abstract] [Full Text] [Related]

  • 18. Imaging of ABC transporter function and expression.
    Colabufo NA, van Waarde A.
    Curr Top Med Chem; 2010 Aug 15; 10(17):1701-2. PubMed ID: 20868364
    [No Abstract] [Full Text] [Related]

  • 19. [Molecular imaging in neurological diseases].
    Reimold M, la Fougère C.
    Radiologe; 2016 Jul 15; 56(7):580-7. PubMed ID: 27306201
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V, Klinkhammer W, Scollard DA, Breitbach K, Reilly RM, Piquette-Miller M, Wiese M.
    Int J Cancer; 2006 Jul 15; 119(2):414-22. PubMed ID: 16646006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.